These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38288823)

  • 1. Lead Identification Through
    Agarwal D; Kumar S; Ambatwar R; Bhanwala N; Chandrakar L; Khatik GL
    Cent Nerv Syst Agents Med Chem; 2024; 24(2):219-242. PubMed ID: 38288823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacophore-based drug design for the identification of novel butyrylcholinesterase inhibitors against Alzheimer's disease.
    Jiang Y; Gao H
    Phytomedicine; 2019 Feb; 54():278-290. PubMed ID: 30668379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacophore mapping-based virtual screening followed by molecular docking studies in search of potential acetylcholinesterase inhibitors as anti-Alzheimer's agents.
    Ambure P; Kar S; Roy K
    Biosystems; 2014 Feb; 116():10-20. PubMed ID: 24325852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of Novel Acetylcholinesterase Inhibitors as Potential Candidates for the Treatment of Alzheimer's Disease.
    Son M; Park C; Rampogu S; Zeb A; Lee KW
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30823604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De-novo Drug Design, Molecular Docking and In-Silico Molecular Prediction of AChEI Analogues through CADD Approaches as Anti-Alzheimer's Agents.
    Pandey S; Singh BK
    Curr Comput Aided Drug Des; 2020; 16(1):54-72. PubMed ID: 30827255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deciphering the Interactions of Bioactive Compounds in Selected Traditional Medicinal Plants against Alzheimer's Diseases via Pharmacophore Modeling, Auto-QSAR, and Molecular Docking Approaches.
    Ojo OA; Ojo AB; Okolie C; Nwakama MC; Iyobhebhe M; Evbuomwan IO; Nwonuma CO; Maimako RF; Adegboyega AE; Taiwo OA; Alsharif KF; Batiha GE
    Molecules; 2021 Apr; 26(7):. PubMed ID: 33915968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacophore-based drug design of AChE and BChE dual inhibitors as potential anti-Alzheimer's disease agents.
    Gao H; Jiang Y; Zhan J; Sun Y
    Bioorg Chem; 2021 Sep; 114():105149. PubMed ID: 34252860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational Investigation of Novel Compounds as Dual Inhibitors of AChE and GSK-3β for the Treatment of Alzheimer's Disease.
    Londhe SG; Shenoy M; Kini SG; Walhekar V; Kumar D
    Curr Top Med Chem; 2024; 24(19):1738-1753. PubMed ID: 38859777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of coumarin derivatives targeting acetylcholinesterase for Alzheimer's disease by field-based 3D-QSAR, pharmacophore model-based virtual screening, molecular docking, MM/GBSA, ADME and MD Simulation study.
    Saha B; Das A; Jangid K; Kumar A; Kumar V; Jaitak V
    Curr Res Struct Biol; 2024; 7():100124. PubMed ID: 38292820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2D-QSAR, molecular docking and MD simulation based virtual screening of the herbal molecules against Alzheimer's disorder: an approach to predict CNS activity.
    Thakur A; Sharma B; Parashar A; Sharma V; Kumar A; Mehta V
    J Biomol Struct Dyn; 2024; 42(1):148-162. PubMed ID: 36970779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of molecular descriptors for design of novel Isoalloxazine derivatives as potential Acetylcholinesterase inhibitors against Alzheimer's disease.
    Gurung AB; Aguan K; Mitra S; Bhattacharjee A
    J Biomol Struct Dyn; 2017 Jun; 35(8):1729-1742. PubMed ID: 27410776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico Structure-based Identification of Novel Acetylcholinesterase Inhibitors Against Alzheimer's Disease.
    Iman K; Mirza MU; Mazhar N; Vanmeert M; Irshad I; Kamal MA
    CNS Neurol Disord Drug Targets; 2018 Apr; 17(1):54-68. PubMed ID: 29336270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacophore mapping of the crucial mediators of acetylcholinesterase and butyrylcholinesterase dual inhibition in Alzheimer's disease.
    Adeowo FY; Elrashedy AA; Ejalonibu MA; Lawal IA; Lawal MM; Kumalo HM
    Mol Divers; 2022 Oct; 26(5):2761-2774. PubMed ID: 35067751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Potent Acetylcholinesterase Inhibitors as New Candidates for Alzheimer Disease via Virtual Screening, Molecular Docking, Dynamic Simulation, and Molecular Mechanics-Poisson-Boltzmann Surface Area Calculations.
    Chennai HY; Belaidi S; Bourougaa L; Ouassaf M; Sinha L; Samadi A; Chtita S
    Molecules; 2024 Mar; 29(6):. PubMed ID: 38542869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel acetylcholinesterase inhibitors through 3D-QSAR, molecular docking, and molecular dynamics simulation targeting Alzheimer's disease.
    El Khatabi K; El-Mernissi R; Aanouz I; Ajana MA; Lakhlifi T; Khan A; Wei DQ; Bouachrine M
    J Mol Model; 2021 Sep; 27(10):302. PubMed ID: 34581863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined 3D-QSAR, molecular docking, and molecular dynamics study of tacrine derivatives as potential acetylcholinesterase (AChE) inhibitors of Alzheimer's disease.
    Zhou A; Hu J; Wang L; Zhong G; Pan J; Wu Z; Hui A
    J Mol Model; 2015 Oct; 21(10):277. PubMed ID: 26438408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of ligand-based pharmacophore modeling and docking approach to find novel acetylcholinesterase inhibitors for treating Alzheimer's.
    Dhanjal JK; Sharma S; Grover A; Das A
    Biomed Pharmacother; 2015 Apr; 71():146-52. PubMed ID: 25960230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors as Potential Anti-Alzheimer's Disease Agents Using Pharmacophore, 3D-QSAR, and Molecular Docking Approaches.
    Pang X; Fu H; Yang S; Wang L; Liu AL; Wu S; Du GH
    Molecules; 2017 Jul; 22(8):. PubMed ID: 28933746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of potential PKC inhibitors through pharmacophore designing, 3D-QSAR and molecular dynamics simulations targeting Alzheimer's disease.
    Iqbal S; Anantha Krishnan D; Gunasekaran K
    J Biomol Struct Dyn; 2018 Nov; 36(15):4029-4044. PubMed ID: 29182053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Natural Compounds of the Apple as Inhibitors against Cholinesterase for the Treatment of Alzheimer's Disease: An In Silico Molecular Docking Simulation and ADMET Study.
    Jamal QMS; Khan MI; Alharbi AH; Ahmad V; Yadav BS
    Nutrients; 2023 Mar; 15(7):. PubMed ID: 37049419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.